Now an associate professor of biomedical informatics at Columbia University, Elhadad is far from alone. Endometriosis—a ...

It is important to understand that not every menstrual pain is normal and could be a sign of endometriosis. Understanding these symptoms can help in early diagnosis of the condition and better ...

“To me was like knives inside my body—like someone studying me from the inside.” That’s how Noémie Elhadad describes the pain of endometriosis, a condition she has lived with since she was a teenager.

IT was a hard year in 2024 for Caitríona O’Donnell. She and her husband, Ruairí, began to lose hope that they would ever have a baby. “We’d been childhood sweethearts since our Leaving Cert year,” ...

Doctors warn that severe menstrual pain should never be dismissed as normal, even in teenagers. Endometriosis can begin soon after a girl’s first period, causing symptoms such as intense cramps, ...

Fziomed, Inc. ("Fziomed" or the "Company"), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable gel technology platform, today announced results ...

Dr. Trista Newville and Dr. Jennifer Jaggi break down common treatment options and explain when it's time to see a specialist. Sponsored by Pacific Endometriosis.

When I told my surgeon at the time that kids weren’t on the table, the conversation quickly shifted to needing to freeze my eggs,” Ms Carnibella said. This Endometriosis Awareness Month, the ...

A nurse from a local pharmacy explains the symptoms, treatment options and impact of this often misunderstood condition.

While exotoxins dominate discussions of bacterial infections, endotoxins—cell wall components released upon bacterial death—are equally dangerous. These endotoxins trigger hyperinflammatory responses ...

As a common production contaminant, trace endotoxin triggers immune responses, skews results, and jeopardizes patient safety--risks that are critical in immunology, cell/gene therapy, and vaccine ...

March 11, 2026. Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA) of vipoglanstat, a novel non-hormonal, non-opioid drug ...